Key result
Coexisting intracranial atherosclerosis and white matter hyperintensities significantly predicted an unfavorable functional outcome at 1 year (OR 2.046) compared to patients with neither condition.
Why the study?
The study aimed to evaluate the effect of baseline white matter hyperintensities on 1-year stroke recurrence and functional outcome in patients with intracranial atherosclerosis.
Does the coexistence of intracranial atherosclerosis and white matter hyperintensities predict unfavorable functional outcome or stroke recurrence in patients with acute cerebral ischemia?
Cohort (n=2,076)
Yes
Does the coexistence of intracranial atherosclerosis and white matter hyperintensities predict unfavorable functional outcome or stroke recurrence in patients with acute cerebral ischemia?
Odds Ratio: 2.046 (95% CI 1.23–3.403)
Absolute Event Rate: 26.46% vs 10.05%
p-value: p=0.0058
The coexistence of intracranial atherosclerosis and white matter hyperintensities in patients with acute cerebral ischemia predicts an unfavorable functional outcome at 1 year, but does not independently increase the risk of stroke recurrence.
May refine prognostic stratification after acute cerebral ischemia; leaves open causal mechanisms and intervention targets.
Background and Purpose: This study aimed to assess the effect of baseline white matter hyperintensities (WMH) on 1-year stroke recurrence and the functional outcome for patients with intracranial atherosclerosis (ICAS). Methods: We analyzed 2,076 patients who were enrolled in the Chinese IntraCranial AtheroSclerosis (CICAS) study. ICAS and WMH were diagnosed by baseline magnetic resonance angiography. The primary outcomes were stroke recurrence and unfavorable functional outcome (modified Rankin Scale score 3–6) at 1 year. Results: Of the 2,076 patients included in this study, 1,370 (65.99%) were men, and the mean age was 61.70 years. In total, 224 (10.79%) patients had no WMH and no ICAS, 922 (44.41%) patients had WMH and no ICAS, 157 (7.56%) patients had ICAS and no WMH, and 773 (37.24%) had both WMH and ICAS. During the follow-up period, 87 patients had a recurrent stroke and 333 had unfavorable outcomes at 1 year. Compared to WMH (–) ICAS (–) group, the adjusted odd ratios and 95% confidence interval for unfavorable functional outcome were 0.791 (0.470–1.332; p = 0.3779) in the WMH (+) ICAS (–) group, 1.920 (1.024–3.600; p = 0.0421) in the WMH (–) ICAS (+) group, and 2.046 (1.230–3.403; p = 0.0058) in the WMH (+) ICAS (+) group. There was no significant difference in stroke recurrence risk among the four groups. Conclusion: ICAS coexisting with WMH may predict an unfavorable functional outcome at 1 year, but not stroke recurrence.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) conducted a cohort in Acute cerebral ischemia (n=2,076). Coexisting intracranial atherosclerosis (ICAS) and white matter hyperintensities (WMH) vs. No WMH and no ICAS was evaluated on Unfavorable functional outcome (modified Rankin Scale score 3-6) at 1 year (OR 2.046, 95% CI 1.230-3.403, p=0.0058). Coexisting intracranial atherosclerosis and white matter hyperintensities significantly predicted an unfavorable functional outcome at 1 year (OR 2.046) compared to patients with neither condition.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: